Page last updated: 2024-10-28

fasudil and Cerebral Malaria

fasudil has been researched along with Cerebral Malaria in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research Excerpts

ExcerptRelevanceReference
"The pathology of cerebral malaria is considered to be primarily immunological."5.36Modulation of cerebral malaria by fasudil and other immune-modifying compounds. ( Ginsburg, H; Golenser, J; Hunt, N; McQuillan, JA; Waknine-Grinberg, JH, 2010)
"The pathology of cerebral malaria is considered to be primarily immunological."1.36Modulation of cerebral malaria by fasudil and other immune-modifying compounds. ( Ginsburg, H; Golenser, J; Hunt, N; McQuillan, JA; Waknine-Grinberg, JH, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waknine-Grinberg, JH1
McQuillan, JA1
Hunt, N1
Ginsburg, H1
Golenser, J1

Other Studies

1 other study available for fasudil and Cerebral Malaria

ArticleYear
Modulation of cerebral malaria by fasudil and other immune-modifying compounds.
    Experimental parasitology, 2010, Volume: 125, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Curcumin; Disease Models, Animal; Enzyme Inh

2010